Literature DB >> 15155708

Neonatal tetanus incidence in China, 1996-2001, and risk factors for neonatal tetanus, Guangxi Province, China.

Feng Chai1, D Rebecca Prevots, Xiaojun Wang, Maureen Birmingham, Rongzhen Zhang.   

Abstract

BACKGROUND: In China during 1995-1996 widespread tetanus toxoid (TT) mass vaccination of women of childbearing age in high-risk areas was conducted and neonatal tetanus (NT) surveillance was initiated as part of NT elimination efforts. Despite a subsequent decrease in the estimated rate of NT, the NT disease burden remains high in poorer areas of China.
METHODS: To describe the recent epidemiology of NT in China and estimate its risk, we analysed national surveillance data in China 1996-2001 and conducted a case-control study in one high-risk county (Bobai): 60 hospitalized cases were sex- and calendar-birth year matched to 60 controls from the same or neighbouring villages.
RESULTS: Reported national annual NT incidence decreased from 0.21/1000 live births (LB) in 1997 to 0.16/1000 LB in 2001. Case mothers were more likely to be aged >30 years (odds ratio [OR] = 6; 95% CI: 2.2, 20.2), unschooled (OR = 3.2; 95% CI: 1.1, 11.6), and with an annual income of <1000 yuan ($125 USD) (OR = 6.0; 95% CI: 1.9, 25.6). Only 28% of control mothers and 12% of case mothers reported any TT vaccination. In multivariate analysis, relative to hospital delivery, cases had a 64-fold increased odds of home delivery by a family member or neighbour (95% CI: 8.4, 982.2), and a 13-fold increased odds of home delivery by a traditional birth attendant (95% CI: 1.6, 322.6).
CONCLUSIONS: Improved access to clean deliveries in high-risk areas is critically needed in China. Nonetheless, targeted TT vaccination appears to have helped reduce NT incidence in China.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155708     DOI: 10.1093/ije/dyh073

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  7 in total

Review 1.  Tetanus toxoid immunization to reduce mortality from neonatal tetanus.

Authors:  Hannah Blencowe; Joy Lawn; Jos Vandelaer; Martha Roper; Simon Cousens
Journal:  Int J Epidemiol       Date:  2010-04       Impact factor: 7.196

Review 2.  Vaccines for women for preventing neonatal tetanus.

Authors:  Vittorio Demicheli; Antonella Barale; Alessandro Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2015-07-06

3.  Topical applications of chlorhexidine to the umbilical cord for prevention of omphalitis and neonatal mortality in southern Nepal: a community-based, cluster-randomised trial.

Authors:  Luke C Mullany; Gary L Darmstadt; Subarna K Khatry; Joanne Katz; Steven C LeClerq; Shardaram Shrestha; Ramesh Adhikari; James M Tielsch
Journal:  Lancet       Date:  2006-03-18       Impact factor: 79.321

4.  Risk factors of neonatal tetanus in Wenzhou, China: a case-control study.

Authors:  Zhou Zu-Mu; Shi Hong-Ying; Xu Yi; Hu Cai-Song; Zhang Xiao-Ming; Zhao Li-Na; Xie Zuo-Kai
Journal:  Western Pac Surveill Response J       Date:  2015-07-06

Review 5.  Clean birth and postnatal care practices to reduce neonatal deaths from sepsis and tetanus: a systematic review and Delphi estimation of mortality effect.

Authors:  Hannah Blencowe; Simon Cousens; Luke C Mullany; Anne C C Lee; Kate Kerber; Steve Wall; Gary L Darmstadt; Joy E Lawn
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

6.  The impact of antenatal care, iron-folic acid supplementation and tetanus toxoid vaccination during pregnancy on child mortality in Bangladesh.

Authors:  Tanvir Abir; Felix Akpojene Ogbo; Garry John Stevens; Andrew Nicolas Page; Abul Hasnat Milton; Kingsley Emwinyore Agho
Journal:  PLoS One       Date:  2017-11-01       Impact factor: 3.240

7.  Provincial-level outcomes of China's 'Reducing maternal mortality and eliminating neonatal tetanus' program.

Authors:  Peiran Chen; Mingrong Li; Jun Zhu; Yanping Wang; Yi Mu; Qi Li; Li Dai; Zheng Liu; Juan Liang; Hanming Liu
Journal:  Sci Rep       Date:  2020-08-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.